RELENZA ROTADISK 5 mg/dose

GLAXOSMITHKLINE PTE LTD

GLAXOSMITHKLINE PTE LTD

Therapeutic

Prescription Only

POWDER, METERED

**Dosage and Method of Administration** Relenza is for administration to the respiratory tract by oral inhalation only, using the Diskhaler device provided. Patients scheduled to take inhaled drugs, e.g. fast acting bronchodilators, at the same time as Relenza should be advised to administer that drug prior to administration of Relenza. Treatment of Influenza: _Adults and children 5 years and older:_ The recommended dose of Relenza is two inhalations (2 x 5 mg) twice daily for five days, providing a total daily inhaled dose of 20 mg. For maximum benefit, treatment should begin as soon as possible but no later than 48 hours after onset of symptoms. Prophylaxis: _Adults and juveniles 12 years and older:_ The recommended dose of Relenza is two inhalations (2 x 5 mg) once daily for 10 days, providing a total daily inhaled dose of 10 mg. The treatment can be prolonged for up to one month at the most if the exposure risk lasts more than 10 days. The full course of prophylaxis therapy should be completed as prescribed. _Impaired Renal or Hepatic Function:_ No dose modification is required (see Pharmacokinetic properties – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). _Elderly patients:_ No dose modification is required (see Pharmacokinetic properties – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). _Paediatric patients:_ No dose modification is required (see Pharmacokinetic Properties – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).